Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Archives of Internal Medicine
|
April 1, 1988
The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity
J M Amatruda, J F Richeson, S L Welle, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 3, 2009
Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus
K Nonaka, H Tsubouchi, K Okuyama, et al.
Metabolism: Clinical and Experimental
|
December 1, 1986
Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes
C E Sparks, J D Sparks, M Bolognino, et al.
The Journal of Clinical Investigation
|
January 1, 1995
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice
J M Ren, B A Marshall, M M Mueckler, et al.
Diabetes
|
September 1, 1988
Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes
T K Jackson, A I Salhanick, J D Sparks, et al.
The Journal of Clinical Investigation
|
July 1, 1988
Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes
J D Sparks, C E Sparks, M Bolognino, et al.
Diabetes, Obesity & Metabolism
|
April 27, 2010
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams-Herman, J Johnson, R Teng, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial
Y Iwamoto, N Tajima, T Kadowaki, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
Atsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, et al.
Journal of Human Hypertension
|
July 29, 2005
Knowledge of blood pressure levels and targets in patients with coronary artery disease in the USA
S Cheng, J H Lichtman, J M Amatruda, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Archives of Internal Medicine
|
April 1, 1988
The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity
J M Amatruda, J F Richeson, S L Welle, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 3, 2009
Effects of once-daily sitagliptin on 24-h glucose control following 4 weeks of treatment in Japanese patients with type 2 diabetes mellitus
K Nonaka, H Tsubouchi, K Okuyama, et al.
Metabolism: Clinical and Experimental
|
December 1, 1986
Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes
C E Sparks, J D Sparks, M Bolognino, et al.
The Journal of Clinical Investigation
|
January 1, 1995
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice
J M Ren, B A Marshall, M M Mueckler, et al.
Diabetes
|
September 1, 1988
Insulin-mimetic effects of vanadate in primary cultures of rat hepatocytes
T K Jackson, A I Salhanick, J D Sparks, et al.
The Journal of Clinical Investigation
|
July 1, 1988
Effects of nonketotic streptozotocin diabetes on apolipoprotein B synthesis and secretion by primary cultures of rat hepatocytes
J D Sparks, C E Sparks, M Bolognino, et al.
Diabetes, Obesity & Metabolism
|
April 27, 2010
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams-Herman, J Johnson, R Teng, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2010
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial
Y Iwamoto, N Tajima, T Kadowaki, et al.
Journal of Diabetes Investigation
|
May 21, 2014
Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
Atsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, et al.
Journal of Human Hypertension
|
July 29, 2005
Knowledge of blood pressure levels and targets in patients with coronary artery disease in the USA
S Cheng, J H Lichtman, J M Amatruda, et al.
Page
of 9